AAAAAA

   
Results: 1-13 |
Results: 13
Simultaneous determination of F-beta-alanine and beta-alanine in plasma and urine with dual-column reversed-phase high-performance liquid chromatography
Authors: Van Kuilenburg, ABP Stroomer, AEM Peters, GJ Van Gennip, AH
Citation: Abp. Van Kuilenburg et al., Simultaneous determination of F-beta-alanine and beta-alanine in plasma and urine with dual-column reversed-phase high-performance liquid chromatography, J CHROMAT B, 759(1), 2001, pp. 51-61
Prevalence of a common point mutation in the Dihydropyrimidine dehydrogenase (DPD) gene within the 5 '-splice donor site of intron 14 in patients with severe 5-fluorouracil (5-FU)-related toxicity compared with controls
Authors: Raida, M Schwabe, W Hausler, P Van Kuilenburg, ABP Van Gennip, AH Behnke, D Hoffken, K
Citation: M. Raida et al., Prevalence of a common point mutation in the Dihydropyrimidine dehydrogenase (DPD) gene within the 5 '-splice donor site of intron 14 in patients with severe 5-fluorouracil (5-FU)-related toxicity compared with controls, CLIN CANC R, 7(9), 2001, pp. 2832-2839
Cyclopentenyl cytosine induces apoptosis and increases cytarabine-induced apoptosis in a T-lymphoblastic leukemic cell-line
Authors: Verschuur, AC Brinkman, J Van Gennip, AH Leen, R Vet, RJWM Evers, LM Voute, PA Van Kuilenburg, ABP
Citation: Ac. Verschuur et al., Cyclopentenyl cytosine induces apoptosis and increases cytarabine-induced apoptosis in a T-lymphoblastic leukemic cell-line, LEUK RES, 25(10), 2001, pp. 891-900
Detection of beta-ureidopropionase deficiency with HPLC-electrospray tandem mass spectrometry and confirmation of the defect at the enzyme level
Authors: Van Kuilenburg, ABP Van Lenthe, H Assmann, B Gohlich-Ratmann, G Hoffmann, GF Brautigam, C Wevers, RA Van Gennip, AH
Citation: Abp. Van Kuilenburg et al., Detection of beta-ureidopropionase deficiency with HPLC-electrospray tandem mass spectrometry and confirmation of the defect at the enzyme level, J INH MET D, 24(7), 2001, pp. 725-732
Cyclopentenyl cytosine inhibits cytidine triphosphate synthetase in paediatric acute non-lymphocytic leukaemia: a promising target for chemotherapy
Authors: Verschuur, AC Van Gennip, AH Leen, R Muller, EJ Elzinga, L Voute, PA Van Kuilenburg, ABP
Citation: Ac. Verschuur et al., Cyclopentenyl cytosine inhibits cytidine triphosphate synthetase in paediatric acute non-lymphocytic leukaemia: a promising target for chemotherapy, EUR J CANC, 36(5), 2000, pp. 627-635
Pitfalls in the diagnosis of patients with a partial dihydropyrimidine dehydrogenase deficiency
Authors: Van Kuilenburg, ABP Van Lenthe, H Tromp, A Veltman, PCJ Van Gennip, AH
Citation: Abp. Van Kuilenburg et al., Pitfalls in the diagnosis of patients with a partial dihydropyrimidine dehydrogenase deficiency, CLIN CHEM, 46(1), 2000, pp. 9-17
In vitro inhibition of cytidine triphosphate synthetase activity by cyclopentenyl cytosine in paediatric acute lymphocytic leukaemia
Authors: Verschuur, AC Van Gennip, AH Leen, R Meinsma, R Voute, PA Van Kuilenburg, ABP
Citation: Ac. Verschuur et al., In vitro inhibition of cytidine triphosphate synthetase activity by cyclopentenyl cytosine in paediatric acute lymphocytic leukaemia, BR J HAEM, 110(1), 2000, pp. 161-169
Cytidine triphosphate synthase activity and mRNA expression in normal human blood cells
Authors: Verschuur, AC Van Gennip, AH Muller, EJ Voute, PAT Vreken, P Van Kuilenburg, ABP
Citation: Ac. Verschuur et al., Cytidine triphosphate synthase activity and mRNA expression in normal human blood cells, BIOL CHEM, 380(1), 1999, pp. 41-46
Radiochemical assay for determination of dihydropyrimidinase activity using reversed-phase high-performance liquid chromatography
Authors: Van Kuilenburg, ABP Van Lenthe, H Van Gennip, AH
Citation: Abp. Van Kuilenburg et al., Radiochemical assay for determination of dihydropyrimidinase activity using reversed-phase high-performance liquid chromatography, J CHROMAT B, 729(1-2), 1999, pp. 307-314
Genotype and phenotype in patients with dihydropyrimidine dehydrogenase deficiency
Authors: Van Kuilenburg, ABP Vreken, P Abeling, NGGM Bakker, HD Meinsma, R Van Lenthe, H De Abreu, RA Smeitink, JAM Kayserili, H Apak, MY Christensen, E Holopainen, I Pulkki, K Riva, D Botteon, G Holme, E Tulinius, R Kleijer, WJ Beemer, FA Duran, M Niezen-Koning, KE Smit, GPA Jakobs, C Smit, LME Moog, U Spaapen, LJM Van Gennip, AH
Citation: Abp. Van Kuilenburg et al., Genotype and phenotype in patients with dihydropyrimidine dehydrogenase deficiency, HUM GENET, 104(1), 1999, pp. 1-9
Clinical and biochemical abnormalities in a patient with dihydropyrimidinedehydrogenase deficiency due to homozygosity for the C29R mutation
Authors: Van Kuilenburg, ABP Vreken, P Riva, D Botteon, G Abeling, NGGM Bakker, HD Van Gennip, AH
Citation: Abp. Van Kuilenburg et al., Clinical and biochemical abnormalities in a patient with dihydropyrimidinedehydrogenase deficiency due to homozygosity for the C29R mutation, J INH MET D, 22(2), 1999, pp. 191-192
Profound variation in dihydropyrimidine dehydrogenase activity in human blood cells: major implications for the detection of partly deficient patients
Authors: Van Kuilenburg, ABP van Lenthe, H Blom, MJ Mul, EPJ Van Gennip, AH
Citation: Abp. Van Kuilenburg et al., Profound variation in dihydropyrimidine dehydrogenase activity in human blood cells: major implications for the detection of partly deficient patients, BR J CANC, 79(3-4), 1999, pp. 620-626
A radiochemical assay for beta-ureidopropionase using radiolabeled N-carbamyl-beta-alanine obtained via hydrolysis of [2-C-14] 5,6-dihydrouracil
Authors: Van Kuilenburg, ABP Van Lenthe, H Van Gennip, AH
Citation: Abp. Van Kuilenburg et al., A radiochemical assay for beta-ureidopropionase using radiolabeled N-carbamyl-beta-alanine obtained via hydrolysis of [2-C-14] 5,6-dihydrouracil, ANALYT BIOC, 272(2), 1999, pp. 250-253
Risultati: 1-13 |